Here are five things to know:
1. Mr. Yared believes the device tax restricts big device companies from investing in and promoting smaller companies’ devices.
2. Small device companies’ window for success and growth narrows as expenses rise.
3. Medtech companies typically spend $74 million to progress from inception to fruition. The same process cost roughly $32 million 10 years ago.
4. With a clear desire to repeal the device tax, Mr. Yared said he had “a high level of confidence that it will happen this year.”
5. Mr. Yared is chief executive of CVRx, a small medical device company based in Maple Grove, Minn., and was recently named AdvaMed chairman.
More articles on devices:
Baxter highlights FLOSEAL hemostatic agent enhancements for spine, cardiac surgery: 5 highlights
Implanet intends to transfer share listing from Euronext to Alternext Paris: 5 key notes
Spinal implant 3D printing: 5 findings from 2 key cases
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
